2021
DOI: 10.1007/s11547-021-01404-1
|View full text |Cite
|
Sign up to set email alerts
|

Portal vein puncture-related complications during transjugular intrahepatic portosystemic shunt creation: Colapinto needle set vs Rösch-Uchida needle set

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 43 publications
0
10
0
Order By: Relevance
“…In this phase, radiologist should evaluate: (a) the presence of free fluid, (b) the state of the surgical margins and the remnant liver parenchyma, (c) vascular evaluation (portal vein, hepatic veins, and hepatic arterial branches) as well as any other sites subjected to resection [ 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 ].…”
Section: Non Anatomic Liver Resectionmentioning
confidence: 99%
“…In this phase, radiologist should evaluate: (a) the presence of free fluid, (b) the state of the surgical margins and the remnant liver parenchyma, (c) vascular evaluation (portal vein, hepatic veins, and hepatic arterial branches) as well as any other sites subjected to resection [ 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 ].…”
Section: Non Anatomic Liver Resectionmentioning
confidence: 99%
“…CT usually confirms the diagnosis with the typical findings of a central hypodense core of fluid material surrounded by a hyperdense rim and a hypodense outer ring as a double target appearance [ 115 ]. Percutaneous drainage should be considered in the case of infected collections (abscesses and bilomas) ( Figure 4 ) [ 117 , 118 , 119 ], when a worsening of laboratory and clinical parameters occurs despite antibiotic therapy.…”
Section: Complicationsmentioning
confidence: 99%
“…With regard to patients, both HCC patients and colorectal liver metastases patients [ 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 ] could have impaired liver function due to cirrhosis or drug-induced liver injury [ 114 ], so, they are at increased risk of bleeding ( Figure 1 ) or biliary damage ( Figure 2 ). In addition, in immunocompromised patients, the risk of infection of the ablated area is high, with consequent risk of liver abscess [ 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 ].…”
Section: Complications and Risk Assessmentmentioning
confidence: 99%